AusPAR: Reslizumab

Australian Public Assessment Report

AusPAR

AusPAR: Reslizumab [PDF, 1.27 MB]

AusPAR: Reslizumab [Word, 1.96 MB]

Attachment: Product Information: Reslizumab [PDF, 229.24 KB]

Attachment: Product Information: Reslizumab [Word, 138.35 KB]

Attachment: Extract from Clinical Evaluation: Reslizumab [PDF, 2.51 MB]

Attachment: Extract from Clinical Evaluation: Reslizumab [Word, 5.83 MB]

Device/Product Name

Cinqair / Cinqaero

Active ingredients

Reslizumab

AusPAR Date

5 June 2018

Published

14 June 2018

Submission Number

PM-2016-02101-1-5

Submission Type

New chemical (biological) entity

Decision

Approved